Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
3
×
clinical trials
life sciences
national blog main
boston blog main
boston top stories
eli lilly
fda
merck
migraine
national
national top stories
new york blog main
access biotechnology
access industries
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
allergan
alzheimer's disease
amgen
anemia
antibiotics
atlas ventures
axial spondyloarthritis
bausch health
biogen
biohaven
blood diseases
blood disorders
boston
boston university
boulder/denver blog main
boulder/denver top stories
brian macdonald
bristol-myers squibb
cancer
What
new
3
×
adults
advance
allergan
anemia
approval
approved
bio
biogen’s
biopharmaceutical
blood
body
carry
cells
class
companies
convo
disc
drug
earlier
failures
fda
having
health
iron
launches
lead
littered
little
lungs
medicine
medicines
migraine
monday
nash
need
news
nod
oxygen
pill
Language
unset
Current search:
new
×
abbvie
×
biotech
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More